A group of Stanford researchers has combined a liquid biopsy platform with a multiplexed real-time PCR assay to rapidly detect acute fungal infections in a patient's bloodstream.
The team is currently performing a prospective study using the platform on patients at high-risk for fungal infections out of its CLIA lab, and hopes to eventually be able to offer the test for early detection and treatment monitoring.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.